Skip to main content
GWGovwatch
CongressBillsCommitteesPresidentMoneyPulseMisconductElectionsMap
Donate

Weekly accountability digest

One email a week with new votes, moving bills, and misconduct updates. No spam.

GW

Govwatch. Public data about Congress, in one place, in plain English.

Built with public data. Not affiliated with the U.S. government.

Explore

  • Officials
  • Legislation
  • Committees
  • Congress Pulse
  • Trending Topics
  • Bipartisan Leaderboard
  • Weekly Digest
  • Misconduct
  • Predictions

Learn

  • How Congress Works
  • How a Bill Becomes Law
  • Campaign Finance 101
  • Glossary

Tools

  • My Representatives
  • Compare Members
  • Bill Watchlist
  • Search
  • District Map
  • Follow the Money
  • Watch Live

Site

  • About
  • Contact
  • Corrections
  • Privacy Policy
  • Terms of Service

Data Sources

Congress.gov API v3
Bills, members, votes
GovInfo API
Floor speeches, reports, bill text
Federal Election Commission (FEC)
Campaign finance
VoteView (UCLA)
Ideology scores (DW-NOMINATE)
GovTrack.us
Misconduct data (CC0)
U.S. Census Bureau
District demographics
Support This Project

This site is free. Donations help cover hosting, API fees, and keeping the data fresh.

All data is sourced from official government APIs and public records. This site is for informational purposes only.

© 2026 Govwatch

HRES359Referred to Committee

Supporting the mission and goals of National Fentanyl Awareness Day in 2025, including increasing individual and public awareness of the impact of fake or counterfeit fentanyl pills on families and young people.

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-04-29
Introduced
5
Cosponsors
HRES
ⓘ
Type

Sponsor

Brittany Pettersen
Brittany Pettersen
Democrat · CO · Representative
Votes with party: 96.2% (452 recorded votes)

Full profile: /officials/P000620

Source: Congress.gov · FEC

Cosponsors (5)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

  • Addison P. McDowell (R-NC-6)Original· 2025-04-29
  • Brian K. Fitzpatrick (R-PA-1)Original· 2025-04-29
  • Joe Neguse (D-CO-2)Original· 2025-04-29
  • Lisa C. McClain (R-MI-9)Original· 2025-04-29
  • Lori Trahan (D-MA-3)Original· 2025-04-29

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

2025-04-29

Source: Congress.gov

Committee Activity

Currently in

  • House Committee on Energy and CommerceReferred To · 2025-04-29
  • House Committee on the JudiciaryReferred To · 2025-04-29

Previously

  • Judiciary CommitteeReferred To · 2025-04-29
  • Energy and Commerce CommitteeReferred To · 2025-04-29

Plain-English Summary

This resolution supports the designation of National Fentanyl Awareness Day to bring attention to the impact of fake or counterfeit fentanyl pills.

Plain-English rewrite of the Congressional Research Service summary published on Congress.gov. Cached and reviewed.

Subjects

Health
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.

  • HR8989Evidence-Based Youth Suicide Prevention Act of 2026
    Referred to Committee · 2026-05-21
  • HR8859Creating Early Childhood Leaders Act
    Referred to Committee · 2026-05-15
  • HJRES166Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Bulletin 2015-07 re: in-person collection of consumer debt".
    Referred to Committee · 2026-04-30
  • HJRES165Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Fair Credit Reporting; Permissible Purposes for Furnishing, Using, and Obtaining Consumer Reports".
    Referred to Committee · 2026-04-30